CorMedix Inc. (CRMD)

CorMedix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	226	206	174	173	239	187
Market Cap Growth	26.54%	18.30%	0.53%	-27.41%	27.84%	37.47%
Enterprise Value	168	131	116	109	193	158
PE Ratio	-	-4.45	-5.86	-6.14	-10.84	-4.29
PS Ratio	-	-	2663.45	907.60	997.97	659.28
PB Ratio	3.90	2.94	3.16	2.76	5.40	7.90
P/FCF Ratio	-5.10	-5.32	-7.09	-7.67	-10.81	-12.38
P/OCF Ratio	-5.14	-5.37	-7.15	-8.19	-10.87	-12.41
EV/Sales Ratio	-	-	1774.96	568.88	807.74	558.65
EV/EBITDA Ratio	-3.40	-2.83	-3.85	-3.70	-7.15	-7.67
EV/EBIT Ratio	-3.39	-2.82	-3.84	-3.69	-7.11	-7.64
EV/FCF Ratio	-3.83	-3.37	-4.72	-4.81	-8.75	-10.49
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.00
Debt / EBITDA Ratio	-0.01	-0.01	-0.03	-0.03	-0.04	0.00
Debt / FCF Ratio	-0.01	-0.02	-0.03	-0.04	-0.05	0.00
Quick Ratio	6.15	6.68	9.34	12.28	11.18	4.89
Current Ratio	6.65	6.97	9.44	12.44	11.58	5.04
Asset Turnover	0	0	0.00	0.00	0.01	0.01
Interest Coverage	-1459.41	-1350.16	-1141.27	-1846.86	-817.55	-26.29
Return on Equity (ROE)	-77.20%	-72.30%	-51.00%	-39.00%	-74.20%	-204.00%
Return on Assets (ROA)	-67.30%	-64.00%	-46.30%	-36.50%	-62.50%	-147.50%
Return on Capital (ROIC)	-93.18%	-69.14%	-54.82%	-46.20%	-60.15%	-88.82%
Earnings Yield	-22.19%	-22.48%	-17.05%	-16.28%	-9.23%	-23.31%
FCF Yield	-20.18%	-18.80%	-14.11%	-13.03%	-9.25%	-8.08%
Buyback Yield / Dilution	-30.42%	-26.39%	-6.92%	-31.87%	-18.26%	-35.56%
Total Shareholder Return	-30.42%	-26.39%	-6.92%	-31.87%	-18.26%	-35.56%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).